Weight loss jab could be used to slow progression of Alzheimer’s disease in major breakthrough

Weight loss jabs could be used to treat Alzheimer’s disease after a study found the drug may slow cognitive decline.

Huge Alzheimer's breakthrough as weight-loss jab already prescribed to thousands on the NHS is found to slow progression of memory-robbing illness

Liraglutide - sold under the brand name Saxenda - is often offered to people with with a BMI of over 30 as it improves blood ...
LBC

Weight-loss jab found to slow progression of Alzheimer's disease in huge breakthrough

Brain scans in patients revealed the drug slowed brain volume loss by around half compared to the placebo. A weight-loss jab ...

Popular fat jab could slow Alzheimer’s by slashing brain shrinkage and boosting memory

A FAT jab could help slow down Alzheimer’s by slashing brain shrinkage, according to a small British study. Liraglutide, the ...
Drug Store News

Lupin launches generic Victoza

Generic Victoza is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older, with Type 2 diabetes mellitus. Lupin is releasing ...
NJBIZ

Teva wins FDA nod for first generic GLP-1 weight-loss drug

Teva Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration for the first generic GLP-1 medication for weight loss, the Parsippany-based company announced Aug. 28. The ...
WDAF-TV

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...